Abstract Introduction: Rheumatic diseases are considered public health problems affecting millions of people worldwide resulting in high and rising health-care costs. In this work, Fourier Transform Infrared spectroscopy associated to Partial Least Square regression (PLS) analysis was used to diagnose rheumatoid arthritis (RA) from human serum. Methods: The sera of 94 individuals were collected, which included 47 from rheumatic patients and 47 from healthy individuals. The results from PLS analysis were compared to standard clinical trials such as anti-citrullinated peptide antibodies, C-Reactive protein, and Rheumatoid factor. Results: For clinical diagnosis, the anti-citrullinated peptide antibodies of second generation proved to be the most specific to diagnosis rheumatoid arthritis even after long periods of drug therapy. Conclusions: The qualitative PLS analysis has shown higher values of IgM of RA group, but the difference was very small. The RA patients were under medication, which interfered with the IgM concentration.
Introduction
Rheumatic diseases are considered public health problems affecting millions of people worldwide resulting in high and rising health-care costs (Cheng et al., 2010; Desai et al., 2010; Waljee and Chung, 2011) . For example, in 2003, the United States of America spent a total of 128 billion US$ on rheumatoid arthritis (RA), which is just one type of rheumatic disease (Birch and Bhattacharya, 2010; Centers…, 2011) . Of this sum, 3.6 billion US$ were spent on drug therapies (Waljee and Chung, 2011) and about US$ 14,000 on cardiovascular disease associated with an increased prevalence of coronary artery disease present in RA (Desai et al., 2010) . In the period from 2007 to 2009, US statistical data indicate an increase of approximately a million of new RA cases per year (Cheng et al., 2010) .
RA affects approximately 0.5-1% of the world population (Hambright et al., 2011; Martínez et al., 2011) , being more common in women than in men, and in ages between 40 and 60 years (Ebringer et al., 2010) . RA is the most common systemic autoimmune disease in the world (Haro et al., 2011) , and it causes functional disability and premature death. Approximately 70% of patients have irreversible joint destruction and 80% of active young adults in the labor market are affected by stiffness and devastating pain (Filipovic et al., 2011) . This situation generates a big loss of daily activities and vocational productivity resulting in significant reduction in quality of life (Waljee and Chung, 2011) .
Regarding the etiology of the disease, cigarette smoking is described as a possible risk factor for the onset or worsening of RA. Smoking is associated with a worse prognosis of the disease (Karlson and Deane, 2012; Okamoto et al., 2011; Ruiz-Esquide and Sanmartí, 2012) . In contrast, little has been said about better eating habits or the benefits of physical activity in this population. The implementation of programs of physical training and nutrition education could provide greater independence and quality of life to RA patients (Külkamp et al., 2009; Plasqui, 2008) . Therefore, it is necessary to explore theses parameters within a public health system.
The clinical approach to diagnosis RA is based on the standard procedure established by the ACR (American College of Rheumatology) in 1987. However, this has been widely criticized due to the lack of sensitivity for early detection of the disease. Therefore, the ACR and European League Against Rheumatism (EULAR) has developed a new set of criteria to classify RA based on new laboratory parameters such as anti-citrullinated peptide antibodies (anti-ACPA), C-Reactive protein (CRP), and Rheumatoid factor (RF). The new set of criteria aims to identify early RA patients in order to institute early drug therapy, thereby reducing the functional disability and articular lesions (Aletaha et al., 2010) . High concentrations of CRP, RF, and ACPA in serum are associated with unfavorable outcomes, including persistent disease, joint destruction, and functional Volume 30, Número 1, p. 54-63, 2014 disability. The studies correlating clinical trials (symptoms and signs) with radiographic exams have shown that patients with low titre and/or negative RF/ACPA have a better prognosis (Malaviya et al., 2009 ). This RF in RA patients may have different classes of gammaglobulins such as IgM, IgG, or IgA. Nevertheless, classes of IgM and IgG-RF are more correlated with the disease and are abundantly produced by plasma cells in synovial tissue (Duquerroy et al., 2007; Firestein et al., 2009) .
The ACR and EULAR have been using these biomarkers as part of the classification criteria for early diagnosis, thereby ensuring the opportunity of early treatment and prevention of irreversible deformities. However, there are some problems in the tests due to the mismatch between specificity and sensitivity. The ACR uses RF as a biomarker that can be detected in 70-80% of patients with RA, but it can also be found in other rheumatic diseases. Therefore, it is a test for a non-specific biomarker, which is also present in infections and about 5-10% of healthy individuals (Birch and Bhattacharya, 2010; Ryu et al., 2011) . The CRP test is based on the increase in serum C-reactive protein, which is synthesized in great amounts immediately after any tissue damage. Thus, CRP test is not specific and it is elevated in all inflammatory and infectious processes as well as in the RA. Elevated plasma levels are detected within 4 to 6 hours after injury and peak levels are found after 24 to 72 hours (Otterness, 1994) . ACPA antibody is considered the most specific marker for RA, but the sensitivity is not greater than 70% .
Another possibility for early diagnosis is the antiperinuclear factor (APF) antibody, which was originally described by Nienhius et al. (1964) by indirect immunofluorescence technique. APF is an autoantibody that reacts against antigens present in keratohyalin granules of human oral mucosa. APF is distributed predominantly around the nucleus of keratinocytes (Vander Cruyssen et al., 2005) . High levels of APF are considered specific for RA and the molecular characterization of these antigens resulted in the discovery of citrullinated peptides. From this characterization, enzyme immunoassays for antibodies to citrullinated peptide are produced commercially (ACPA) by ELISA method. These new laboratory tests combined with imaging methods such as ultrasound and magnetic resonance imaging of affected joints have largely contributed to the early diagnosis, which is very important to improve patient´s quality of life (Hsin-Hua et al., 2010; Narváez et al., 2008; Nienhius et al., 1964; Østergaard et al., 2008) . However, most immunochemical assays for anti-CCP (ELISA) and APF have limited utility for routine clinical practice due to the complexity of procedures and the need for qualified technicians (Liao et al., 2011; Santos et al., 1997) .
The several medications administrated to RA patients lead to changes in the serum composition. The persistent and progressive inflammation of the synovial tissue causes joint destruction, affecting mainly the hands (Waljee and Chung, 2011) . To try to combat or reduce the loss caused by this disease, the medical community makes use of nonsteroidal anti-inflammatory drugs (NSAID) and low-dose glucocorticoids, associated with modifying antirheumatic drugs (DMARDs) (Elefant et al., 2010; Mouterde et al., 2011) .
Nevertheless, the negative sides effects of steroids are a limiting factor, and the dose must be the lowest possible to achieve therapeutic benefit. NSAIDs should not be used alone, as they do not change the course of the disease. Most RA treatment includes NSAIDs for pain control, glucocorticoids and the initiation of a DMARDs (Birch and Bhattacharya, 2010) .
Fourier Transform Infrared Spectroscopy (FTIR) analysis has the potential to provide rapid results and may be adapted for a clinical test with high values of sensitivity and specificity (Carvalho et al., 2011; Naumann, 2008; Raniero et al., 2011) . In this article, FTIR (Petibois et al., 1999; Sankari et al., 2010) was used as tool to investigate sera of RA and normal (N) individuals, using Partial Least Square (PLS) regression analysis (Muñoz de la Peña et al., 2007) . The results were compared to different laboratory techniques such as CRP, RF, anti-CCP, APF. In addition, we also analyzed possible interference of medication and food in the two evaluated groups. Selection of the volunteers was done through a questionnaire with information about diet, medications, lifestyle, and the most recent meal. The parameters of exclusion and inclusion were pre-adjusted for both groups. The healthy group was comprised only of women from 30 to 60 years old, due to the predominance of the disease in women, and the disease group was formed by women with confirmed RA diagnosis, according to criteria established by the ACR 2010.
Methods

Blood samples
The 94 blood samples were collected at UNIFESP (Federal University of São Paulo) and the Department of Hemotherapy and Hematology of São José dos Campos, in agreement with requirements and recommendations of Brazilian Society of Clinical Pathology (SBPC)/Laboratory of Medicine for venous blood (Andriolo et al., 2009) . Of the blood samples, 47 were from patients with RA (chronic phase and with long-term drug therapy) and 47 from healthy subjects. The procedure adopted for collecting venous blood was as follows: 1) Collection of whole blood in the antecubital region of the right arm using venipuncture; 2) Storage in sterile tube, gel-barrier vacuum (BD Vacutainer SST Advance Tube, 5 mL, Gold) for 30 min at room temperature; 3) Centrifugation at 4000 g for 6 min; and 4) Separation of serum, that was stored in polypropilene tubes and placed in sealed polypropylene styrene boxes for transportation and storage of the material at -23 °C.
Clinical analysis
The analysis of rheumatoid factor and C-reactive protein were started immediately after the blood collection. RF and CRP were evaluated by latex agglutination test (Wama Diagnóstica ® ), based on indirect agglutination of latex particles coated with human IgG and monoclonal anti-CRP antibody, respectively.
The sensitivity of the tests corresponded to 8 Ul/ ml for RF and 6 mg/liter for CRP. The tests for APF (antiperinuclear factor) and ACPA 2nd generation were performed at Rheumatology Division at Escola Paulista de Medicina. The determination of ACPA2 was done using Quanta LiteTM CCP2 IgG Elisa, kit (INOVA Diagnostics, Inc., San Diego, CA, USA), according to the manufacturer's instructions, which set the cut off at 20 U/ml. ACPA titers between 20 and 39 U/ml were considered weakly positive, between 40 and 59 U/ml as moderately positive, and ≥ 60U/ml as strongly positive. APF was determined as described by Hoet et al. (1991) with slight modifications as established in Brazil by Santos et al. (1997) .
Medications and diet
The drugs used in the RA group were nonbiological and biological. The non-biological DMARDs were Methotrexate (MTX), leflunomide, hydroxychloroquine, sulfazalasine, and cyclosporine. The biological medications are divided in subgroup such as: 1) TNF blockers: Adalimumab, etanercept, and infliximab; 2) Depletors B lymphocytes: Rituximab; 3) Modulators of co-stimulation: Abatacept. For pain control and inflammation of the joints, nonsteroidal anti-inflammatory drugs (NSAIDs) were used alone or combined with low doses of glucocorticoids (up to 15 mg of prednisone) (Bértolo et al., 2007) . In the N group, the only drugs allowed were anti-hypertensives and oral hormone replacement therapy.
The information about the most recent meal from RA and N groups was evaluated through the TACO 
Fourier Transform Infrared Spectroscopy
A thin serum film was made with a drop (1 µl) of the samples deposited on calcium fluoride (CaF 2 ) window and dried using an Eppendorf Concentrator 5301. The spectra of the samples were recorded in the range of 4000-900 cm , using a FTIR spectrometer (Perkin-Elmer, Spotlight 400). The spectra were collected using the single detector mode of the microscope. To analyze spectral data, the spectrum Image, Spotlight 400 Software, version 3.6.2 was used.
Statistical analysis
The values obtained through the questionnaire were evaluated, consolidated, and tabulated using a binomial distribution by the statistic software IBM SPSS ® 19.0. PLS analysis was constructed from serum proteins known as bovine serum albumin (BSA) and human immunoglobulin M class (IgM) antibodies, which were purchased from Sigma Aldrich. The human and bovine albumins have very similar primary structures, both being widely used in biochemical and biophysical studies (Gelamo and Tabak, 2000) . From the spectroscopic view point, an important difference between these proteins is that the albumin has only one tryptophan residue (Trp214) and bovine albumin possesses two tryptophan residues (Trp134 and Trp212) (Cheng, 2012) . Figure 1 shows the sensitivity and specificity values of CRP, RF, APF, and ACPA analysis for N and RA groups. The RF and CRP analysis were performed for both groups. However, the APF and ACPA were done only for RA group due to high specificity of RA diagnosis (Lutteri et al., 2007; Santos et al., 1997; Swart et al., 2012) . All tests have shown high values of specificity, but there are many differences on sensitivity, which will be remarked upon later in this text. Table 1 shows the prevalence of smoking, physical activity and nutrition of N and RA groups. The values p ≤ 0.05 indicate significant differences between the variables, a fact apparent in both N and RA groups. By identifying such similarities, it is possible to correlate the variations found in both groups. Initially it was found that the role of smoking in the inflammatory process is still the subject of study.
Results
Risk factors, diet, and medications
The positive reactions of RF and ACPA antibodies in RA patients were compared in smokers, ex-smokers, and non-smokers, with 24 non-smokers and 23 smokers or ex-smokers. The frequency of positive ACPA assay was similar in both RA subgroups (66.7% and 78.3% with a difference of 11.6% respectively). A positive RF assay was 4.2% for non-smokers and 13% for smokers or ex-smokers, with a difference of 8.8%.
With respect to physical activity, both groups had a sedentary lifestyle with p < 0.05, showing that most of the population studied did not practice regular physical activity.
The statistic results of food taken in the most recent meal found a higher cholesterol level for rheumatic patients compared to normal individuals. However, with respect to other variables both groups showed similar variations, with p < 0.05, demonstrating a percentage intra-group fairly heterogeneous. Table 2 shows the most used medications for rheumatic and healthy individuals in this study. Methotrexate, leflunomide, and prednisone are among the most widely prescribed rheumatics drugs due to their clinical efficacy and low toxicity. In both groups, the use of antihypertensive drugs is present. 
Partial Least Square analysis
Discussion
Our study suggests that even after long-term drug therapy (9 ± 7.9 years), the biomarker ACPA is still present in the circulatory system of rheumatic individuals. This autoantibody showed high specificity and less sensitivity (see Figure 1) . Similarly, Swart et al. (2012) evaluated rheumatic patients (disease duration 8.5 years) using the same ACPA 2nd generation kit, and obtained the following values of sensitivity/ specificity (77.3/98.1%). Van Venrooij et al. (2006) report that the sensitivity of the test ranges between 60% (early RA) and 77% (established RA). The ACPA positive patients usually remain positive despite treatment, and slight declines or even an increase the titers of ACPA may occur (Niewold, 2007) . These differences make it impossible to confirm the effectiveness of anti-rheumatic medications on stability/reduction of this autoantibody. The use of this biomarker in the monitoring of rheumatic patients during treatment or their relation to disease activity is still controversial and unexplored. Currently, it is necessary to standardize evaluative concepts, such as: 1) monitoring of biomarkers before and during the course of the disease; 2) detailing of the medications; and 3) evaluation of clinical and functional signs. Although the ACPA is more specific for RA, it does not exclude the diagnosis of other autoimmune diseases (psoriatic arthritis, systemic lupus, and Sjögren´s syndrome) (Vander Cruyssen, 2005) .
In the present study, the high specificity and reduced sensitivity found in the RF analysis may be due to the low sensitivity of our method by indirect agglutination. Swart et al. (2012) and Liao et al. (2011) observed a higher sensitivity and lower specificity of RF (65.2/89.6% and 67.4/84.3%) by turbidimetry and nephelometry analysis, respectively. This variation can be attributed to the choice of technique used. Nevertheless, the specificity and sensitivity of RF have been improved by the development of enzymelinked immunosorbent assays (ELISA), which permit the detection and quantitative measurement of RF of various IgG-, IgA-, and IgM-RF class immunoglobulins (Vallbracht and Helmke, 2005) . The more specific techniques for testing these classes by ELISA are nephelometry and turbidimetry with 90% sensitivity (Firestein et al., 2009 ). However, discrepancies in the values of RF measurements are widely found (Van der Linden et al., 2011) . Recent data suggest that IgM-RF as well as other RFs play an important role in the pathogenesis of rheumatoid arthritis, thus being one of the more frequently used RFs in research (Ahmed et al., 2010; Zavala-Cerna et al., 2008) . ACPA has a specificity of (91-98%), which is more specific than RF (Romic et al., 2009; Ryu et al., 2011) . The ACPA and RF biomarkers are distinct, but are complementary tools to investigate RA. The CRP and RF values are similar to those described in the literature by indirect agglutination (Carvalho et al., 2011) . Our findings show a decrease in sensitivity values of CRP, which suggests a stabilization of disease activity and joint destruction. In general, improvement in CRP levels indicates that a drug has produced a beneficial effect and may be useful for monitoring effects of therapy (Otterness, 1994) .
The APF analysis had a lower sensitivity compared to with CRP tests. Cordonnier et al. (1996) investigated the APF marker in individuals with RA for a period of 24 months, obtaining a sensitivity/specificity of 28.6/95%. Approximately 50% of patients with RA early-onset and FR-negative (< 2 years) have APF positive and sensitivity/specificity of 59/95% (Santos et al., 1997) . The results shown are consistent with the current literature. Other studies correlating this biomarker with advanced RA could not be found. Table 1 illustrates some risk factors such as smoking and physical inactivity. Our study shows an involvement of smoking in the aggravation of the positivity of RF and ACPA rheumatic markers. However, the role of smoking in the inflammatory process is still unknown. Goeldner et al. (2011) verified that smoking influences the frequency of ACPA2 positivity, increasing by 2.7 times the risk for high titer ACPA. In addition, they observed that the females exposed to tobacco had this rate 7.7 times increased compared to men. Alsalahy et al. (2010) also claims that the levels of ACPA and RF are higher in smokers. Arnson et al. (2010) described that cigarette smoking affects the immune system in diverse ways, both increasing inflammatory allergic and autoimmune reactions, and decreasing systemic activity against infections. Smokers with RA have a disease characterized by a greater proportion of autoantibody positivity. This emphasizes the importance of prevention/eradication of its use in order to avoid respiratory complications and autoimmune conditions. The N and RA groups presented similar characteristics in relation to physical activity, being composed of large number of sedentary individuals. Plasqui (2008) describes that exercise contributes to the improvement of aerobic conditioning and stretching. Consequently, the quality of life and activities of daily living are improved. Furthermore, exercise does not cause deleterious effects on the health of the rheumatoid patient, i.e., it does not increase pain conditions, disease progression, or joint damage. Benhamou et al. (2007) warns that prolonged bed rest in patients with RA may lead to deconditioning and functional decline. In contrast, more detailed investigations about the role of physical activity on the progression of RA should be conducted.
In relation to eating, an important challenge for the present methodology is sample standardization, because serum carries several relevant components, such as protein, lipids, vitamins, carbohydrates, etc. The concentrations of each of these are not constant, but depend on the diet content, interval between meals and sample collection, medications, hormone cycles, genetic factors, metabolic activity, etc. Among this enormous variation, the main objective is to identify biomarkers that could reliable correlate to relevant clinical parameters despite the influence of extraneous factors. Many experts describe the high potential of the infrared technique to diagnose different diseases from serum, but the influences of the above mentioned extraneous factors in spectral interpretation is still largely unknown (Déléris and Petibois, 2003; Petibois et al., 2001; Staib et al., 2001) .
The current study presents the most used medications for treating rheumatism, especially methotrexate (64%) and prednisone (55%). Alarcón et al. (1990) reports that MTX causes a suppression of rheumatoid factors class A and M immunoglobulin in human serum, which leads to a decrease of these autoantibodies in all patients who used the drug. Bathon et al. (2000) describes that MTX reduced disease activity, and this correlated with the absence of progressive radiographic evidence. Lipsky et al. (2000) also reports that MTX associated with infliximab significantly improved clinical benefit and radiographic progression stops. Klaasen et al. (2011) demonstrates that therapy with infliximab reduces the levels of RF and ACPA antibodies after 16 weeks of treatment, which was also confirmed in our results for patients with lowest treatment time, 13 months. Other drugs such as adalimumab and etanercept, also known as biologic DMARDs or TNF blockers, and non-biological DMARDs also showed similar effects, with reduced levels of RF and ACPA throughout drug treatment (Atzeni et al., 2006; Fries et al., 1996) . Thus, the lowest values of autoantibodies were evidenced by efficient treatment through stabilization of immune activities. However, a long period of autoantibodies suppression can lead to a hazardous situation of infections (Ateş et al., 2007) . Glucocorticoids are frequently associated with the described medications above, because prednisone exerts potent inhibitory effects on transcription and action of cytokines (IL-1β, IL-2, IL-3, IL-6, TNF-α, interferon-γ, T helper type 1 (Th1), and granulocyte macrophage colony-stimulating factor), which act in the pathogenesis of RA (Ryu et al., 2011) , but little effect was observed in the immunoglobulin synthesis. Boumpas et al. (1993) report that unlike T cells, B lymphocytes are relatively resistant to the immunosuppressive effects of glucocorticoids. Consequently, low dose glucocorticoids are not expected to affect immunoglobulin levels or synthesis of antibodies in the serum.
In the normal group, the used medications are those associated with aging, contraceptives drugs, and hormone replacement. Hypertension is a fairly common disorder and its prevalence is primarily determined by age and ethnicity (Elliott, 2006) . Lind et al. (1994) found that the long-term use of antihypertensive drugs does not affect serum lipid levels. Nevertheless, a detailed study of such intakes was not done, because just a qualitative survey was applied.
Finally, the PLS method may indicate that the rheumatic group had higher elevation in serum levels of IgM and/or albumin compared to the normal group. These results are also supported by other authors, which showed the potential of PLS model associated with infrared spectroscopy, helping determine concentrations of HSA (human serum albumin) and gammaglobulin (Kasemsumran et al., 2003; Perez-Guaita et al., 2013) .
Our work supports other similar studies that have endeavored to demonstrate that FTIR spectroscopy by PLS method may be of interest as a diagnostic tool, determining not only biomolecules such as proteins, lipids, and gammaglobulins, but also helping to identify changes in molecular composition and structure of chemical entities. Moreover, the clinical analysis of biomarkers showed that even after long-term drug therapy, the ACPA is the most specific and sensitive to monitor the progress of RA. Finally, the influence of medication and eating on both spectral analyzes was discussed. In addition to the possible influence of risk factors such as smoking, the increased levels of ACPA in rheumatic individuals stand out.
